{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:41:44Z","timestamp":1757608904869,"version":"3.44.0"},"reference-count":47,"publisher":"RCNi","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,3]]},"DOI":"10.7748\/ns.2025.e12368","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T08:00:10Z","timestamp":1754899210000},"page":"40-45","source":"Crossref","is-referenced-by-count":0,"title":["An overview of multiple sclerosis: diagnosis, causes and symptom management"],"prefix":"10.7748","volume":"40","author":[{"given":"Megan","family":"Roberts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4499","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"key20250826130123_R1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13317-019-0117-5","article-title":"Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options","volume":"10","year":"2019","journal-title":"Auto-Immunity Highlights"},{"issue":"4","key":"key20250826130123_R2","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neuron.2018.01.021","article-title":"Multiple sclerosis: mechanisms and immunotherapy","volume":"97","year":"2018","journal-title":"Neuron"},{"key":"key20250826130123_R3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-023-06618-z","article-title":"Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations","volume":"625","year":"2024","journal-title":"Nature"},{"key":"key20250826130123_R4","first-page":"439375","article-title":"Outcome measures in multiple sclerosis","year":"2014","journal-title":"Multiple Sclerosis International"},{"issue":"6578","key":"key20250826130123_R5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","year":"2022","journal-title":"Science"},{"key":"key20250826130123_R6","unstructured":"Cemcat (2024) Inclusion of the Optic Nerve in the Diagnostic Criteria Improves the Detection of Multiple Sclerosis Cases. www.cem-cat.org\/en\/new\/inclusion-optic-nerve-diagnostic-criteria-improves-detection-multiple-sclerosis-cases (Last accessed: 14 July 2025.)"},{"issue":"Issue 1","key":"key20250826130123_R7","first-page":"CD002115","article-title":"Management of faecal incontinence and constipation in adults with central neurological diseases","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"key20250826130123_R8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/brain\/awl007","article-title":"Natural history of multiple sclerosis: a unifying concept","volume":"129","year":"2006","journal-title":"Brain"},{"issue":"Issue 10","key":"key20250826130123_R9","first-page":"CD013150","article-title":"Conservative interventions for urinary or faecal incontinence, or both, in adults with multiple sclerosis","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"key20250826130123_R10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.msard.2014.02.006","article-title":"The UK patient experience of relapse in multiple sclerosis treated with first disease modifying therapies","volume":"3","year":"2014","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"3","key":"key20250826130123_R11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nic.2024.03.001","article-title":"Diagnostic criteria for multiple sclerosis, neuromyelitis optica spectrum disorders, and myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease","volume":"34","year":"2024","journal-title":"Neuroimaging Clinics of North America"},{"issue":"4","key":"key20250826130123_R12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7861\/clinmed.2020-0292","article-title":"Clinical presentation and diagnosis of multiple sclerosis","volume":"20","year":"2020","journal-title":"Clinical Medicine"},{"key":"key20250826130123_R13","doi-asserted-by":"crossref","unstructured":"Giovannoni G, Butzkueven H, Dhib-Jalbut S\n et al (2015) Brain Health: Time Matters in Multiple Sclerosis. www.msbrainhealth.org\/wp-content\/uploads\/2021\/05\/brain-health-time-matters-in-multiple-sclerosis-policy-report.pdf (Last accessed: 14 July 2025.)","DOI":"10.21305\/MSBH.001"},{"key":"key20250826130123_R14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.msard.2015.09.002","article-title":"Relapses in multiple sclerosis: relationship to disability","volume":"6","year":"2016","journal-title":"Multiple Sclerosis and Related Disorders"},{"volume-title":"Epstein-Barr Virus","year":"2023","key":"key20250826130123_R15"},{"issue":"6460","key":"key20250826130123_R16","doi-asserted-by":"crossref","first-page":"eaav7188","DOI":"10.1126\/science.aav7188","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility","volume":"365","author":"International Multiple Sclerosis Genetics Consortium","year":"2019","journal-title":"Science"},{"issue":"11","key":"key20250826130123_R17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41582-021-00556-y","article-title":"Apparent changes in the epidemiology and severity of multiple sclerosis","volume":"17","year":"2021","journal-title":"Nature Reviews Neurology"},{"key":"key20250826130123_R18","doi-asserted-by":"crossref","first-page":"102262","DOI":"10.1016\/j.msard.2020.102262","article-title":"Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study","volume":"44","year":"2020","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"1","key":"key20250826130123_R19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1352458508095921","article-title":"Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial","volume":"15","year":"2009","journal-title":"Multiple Sclerosis"},{"issue":"11","key":"key20250826130123_R20","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","year":"1983","journal-title":"Neurology"},{"issue":"6","key":"key20250826130123_R21","first-page":"e4074","article-title":"Keeping it together: the role of social integration on health and psychological well\u2010being among individuals with multiple sclerosis","volume":"30","year":"2022","journal-title":"Health & Social Care in the Community"},{"issue":"9997","key":"key20250826130123_R22","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0140-6736(15)61137-0","article-title":"Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial","volume":"386","year":"2015","journal-title":"The Lancet"},{"issue":"3","key":"key20250826130123_R23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","year":"2014","journal-title":"Neurology"},{"issue":"8","key":"key20250826130123_R24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/jnnp-2016-315238","article-title":"Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study","volume":"88","year":"2017","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"key20250826130123_R25","doi-asserted-by":"crossref","first-page":"101918","DOI":"10.1016\/j.msard.2019.101918","article-title":"The role of the clinical nurse specialist multiple sclerosis, the patients\u2019 and families\u2019 and carers\u2019 perspective: an integrative review","volume":"39","year":"2020","journal-title":"Multiple Sclerosis and Related Disorders"},{"issue":"11","key":"key20250826130123_R26","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.neuron.2023.03.031","article-title":"Remyelination by surviving oligodendrocytes is inefficient in the inflamed mammalian cortex","volume":"111","year":"2023","journal-title":"Neuron"},{"issue":"6","key":"key20250826130123_R27","doi-asserted-by":"crossref","first-page":"e1002053","DOI":"10.1371\/journal.pmed.1002053","article-title":"Obesity and multiple sclerosis: a Mendelian randomization study","volume":"13","year":"2016","journal-title":"PLoS Medicine"},{"key":"key20250826130123_R28","doi-asserted-by":"crossref","first-page":"103666","DOI":"10.1016\/j.msard.2022.103666","article-title":"Uncovering patterns of real-world psychological support seeking and the patient experience in multiple sclerosis","volume":"59","year":"2022","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"key20250826130123_R29","unstructured":"MS Society (2022) Disease Modifying Therapies. www.mssociety.org.uk\/living-with-ms\/treatments-and-therapies\/disease-modifying-therapies (Last accessed: 14 July 2025.)"},{"key":"key20250826130123_R30","unstructured":"Multiple Sclerosis Trust (2022a) Life Choices. mstrust.org.uk\/information-support\/newly-diagnosed\/life-choices (Last accessed: 14 July 2025.)"},{"key":"key20250826130123_R31","unstructured":"Multiple Sclerosis Trust (2022b) Steroids (Methylprednisolone). mstrust.org.uk\/a-z\/steroids-methylprednisolone (Last accessed: 14 July 2025.)"},{"key":"key20250826130123_R32","unstructured":"Multiple Sclerosis Trust (2022c) Disease Modifying Drugs (DMDs). mstrust.org.uk\/information-support\/ms-drugs-treatments\/disease-modifying-drugs-dmds (Last accessed: 14 July 2025.)"},{"key":"key20250826130123_R33","unstructured":"Multiple Sclerosis Trust (2023) Vitamin D. mstrust.org.uk\/a-z\/vitamin-d (Last accessed: 14 July 2025.)"},{"key":"key20250826130123_R34","unstructured":"Multiple Sclerosis Trust (2024a) How Common is Multiple Sclerosis? mstrust.org.uk\/information-support\/about-ms\/how-common-multiple-sclerosis (Last accessed: 14 July 2025.)"},{"key":"key20250826130123_R35","unstructured":"Multiple Sclerosis Trust (2024b) How is MS Diagnosed? mstrust.org.uk\/information-support\/ms-symptoms-diagnosis\/how-is-ms-diagnosed (Last accessed: 14 July 2025.)"},{"key":"key20250826130123_R36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-052920-040318","article-title":"The immune response in multiple sclerosis","volume":"17","year":"2022","journal-title":"Annual Review of Pathology"},{"key":"key20250826130123_R37","unstructured":"Mynors G, Roberts M, Bowen A\n (2016) Improving the Efficiency of Disease Modifying Drug Provision. mstrust.org.uk\/health-professionals\/resources\/service-development\/improving-efficiency-dmd-provision (Last accessed: 14 July 2025.)"},{"volume-title":"NICE guideline No. 220","year":"2022","author":"National Institute for Health and Care Excellence","key":"key20250826130123_R38"},{"key":"key20250826130123_R39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.neuro.30.051606.094309","article-title":"Axon-glial signalling and the glial support of axon function","volume":"31","year":"2008","journal-title":"Annual Review of Neuroscience"},{"issue":"1","key":"key20250826130123_R40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000341902","article-title":"Modelling genetic susceptibility to multiple sclerosis with family data","volume":"40","year":"2013","journal-title":"Neuroepidemiology"},{"key":"key20250826130123_R41","unstructured":"Public Health England (2020) Multiple Sclerosis: Prevalence, Incidence and Smoking Status - Data Briefing. www.gov.uk\/government\/publications\/multiple-sclerosis-prevalence-incidence-and-smoking-status\/multiple-sclerosis-prevalence-incidence-and-smoking-status-data-briefing (Last accessed: 14 July 2025.)"},{"issue":"2","key":"key20250826130123_R42","first-page":"245","article-title":"Association between cigarette smoking and multiple sclerosis: a review","volume":"77","year":"2019","journal-title":"JAMA Neurology"},{"issue":"2","key":"key20250826130123_R43","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1037\/rep0000032","article-title":"Coping among individuals with multiple sclerosis: evaluating a goodness-of-fit model","volume":"60","year":"2015","journal-title":"Rehabilitation Psychology"},{"issue":"1","key":"key20250826130123_R44","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40120-017-0086-4","article-title":"Vitamin D and multiple sclerosis: a comprehensive review","volume":"7","year":"2018","journal-title":"Neurology and Therapy"},{"key":"key20250826130123_R45","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1186\/s12913-021-07012-z","article-title":"Patients experiences with multiple sclerosis disease-modifying therapies in daily life \u2013 a qualitative interview study","volume":"21","year":"2021","journal-title":"BMC Health Services Research"},{"issue":"2","key":"key20250826130123_R46","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","year":"2018","journal-title":"The Lancet Neurology"},{"issue":"2","key":"key20250826130123_R47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7224\/1537-2073.2020-087","article-title":"A qualitative study of health care professionals\u2019 views on bowel care in multiple sclerosis: whose job is it anyway?","volume":"24","year":"2022","journal-title":"International Journal of MS Care"}],"container-title":["Nursing Standard"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.rcni.com\/doi\/pdf\/10.7748\/ns.2025.e12368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T07:40:18Z","timestamp":1756885218000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.rcni.com\/doi\/10.7748\/ns.2025.e12368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":47,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,8,11]]},"published-print":{"date-parts":[[2025,9,3]]}},"alternative-id":["10.7748\/ns.2025.e12368"],"URL":"https:\/\/doi.org\/10.7748\/ns.2025.e12368","relation":{},"ISSN":["0029-6570","2047-9018"],"issn-type":[{"type":"print","value":"0029-6570"},{"type":"electronic","value":"2047-9018"}],"subject":[],"published":{"date-parts":[[2025,8,11]]}}}